Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 10/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13761019 | 0.89 | PDE4B (0.42) | PDE4BROCK2MAPK1ADORA2A | |
| SCHEMBL13750901 | 0.89 | PDE4B (0.42) | PDE4BROCK2MAPK1ADORA2A | |
| SCHEMBL1365292 | 0.89 | PDE4B (0.41) | PDE4BROCK2CHRM3 | |
| SCHEMBL4354865 | 0.89 | PDE4B (0.42) | PDE4BENPP2CHRM3MAPK1 | |
| SCHEMBL13760880 | 0.89 | PDE4B (0.44) | PDE4BROCK2CHRM3 | |
| SCHEMBL1363909 | 0.89 | PDE4B (0.44) | PDE4BROCK2CHRM3 | |
| SCHEMBL1363194 | 0.89 | CHRM3 (0.46) | PDE4BCHRM3 | |
| SCHEMBL1364238 | 0.88 | PDE4B (0.44) | PDE4BCHRM3 | |
| SCHEMBL8009055 | 0.88 | CHRM3 (0.46) | PDE4BCHRM3 | |
| SCHEMBL1363352 | 0.88 | CHRM3 (0.43) | PDE4BCHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249830-A1 | DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS | Glaxo Group Limited (GB) | 2010-11-17 | — | — | EP | disclosed |
| WO-2009100170-A1 | DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | WO | disclosed |